Biomedical Engineering Reference
In-Depth Information
55. Losick R, Dworkin J. Linking asymmetric division to cell fate: teaching an old
microbe new tricks. Genes Dev 1999;13:377-381.
56. Kell DB, Young. Bacterial dormancy and culturability: the role of autocrine growth
factors. Curr Opin Microbiol 2000;3:238-243.
57. Sachidanandham R, Gin KY-H. A dormancy state in nonspore-forming bacteria. Appl
Microbiol Biotechnol 2009;81:927-941.
58. Bryce D. Tests for the sterility of pharmaceutical preparations. J Pharm Pharmacol
1956;8:561-572.
59. Spicher G. Die mikrobiologie zwischen anspruch und wirklichkeit. Zentralbl Hyg.
Unmweltmed 1993;3:223-235.
60. Moldenhauer JS. Towards and improved sterility test. PDA J Pharm Sci Technol
2004;58(6):284-286.
61. Odlaug TO. Sterility assurance for terminally sterilized products without end-product
sterility testing. J Parenter Drug Assoc 1984;38(4):141-147.
62. Nauta MJ. Separation of uncertainty and variability in quantitative microbial risk
assessment models. Int J Food Microbiol 2000;57:9-18.
63. Thompson KM, Burmaster DE, Crouch EAC. Monte Carlo techniques for quantitative
uncertainty analysis in public health risk assessments. Risk Anal 1992;12:53-63.
64. Whyte W, Eaton T. Assessing microbial risk to patients from aseptically manufactured
pharmaceuticals. Eur J Parenter Pharm Sci 2004;9(3):71-77.
65. Vose D. Quantitative Risk Analysis: A Guide to Monte Carlo Simulation Modeling.
New York: John Wiley & Sons. Inc.; 1996.
66. Smid JH, Verloo D, Barker GC, Havelaar AH. Strengths and weaknesses of Monte
Carlo simulation models and Bayesian belief networks in microbial risk assessment.
Int J Food Microbiol 2010;139(1):S57-S63.
67. Miller MJ, Lindsay H, Valverde-Ventura R, O'Connor MJ. Evaluation of the BioVigi-
lant IMD-A, a novel optical spectroscopy technology for the continuous and real-time
environmental monitoring of viable and nonviable particles. Part I: Review of the
technology and comparative studies with conventional methods. PDA J Pharm Sci
Technol 2009;63(3):244-257.
68. Miller MJ, Walsh MR, Shrake JL, Dukes RE, Hill DB. Evaluation of the BioVigi-
lant IMD-A, a novel optical spectroscopy technology for the continuous and real-
time environmental monitoring of viable and nonviable particles. Part II: Case
studies in environmental monitoring during aseptic filling, intervention assessments
and glove integrity testing in manufacturing isolators. PDA J Pharm Sci Technol
2009;63(3):258-282.
Search WWH ::
Custom Search